The c-Myc target gene network

Dang, Chi V., O’Donnell, Kathryn A., Zeller, Karen I., Nguyen, Tam, Osthus, Rebecca C., Li, Feng·2006·Seminars in Cancer Biology

Cited by (1,000)

Items 601–700 of 1,000

  1. Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
    Xiaonan Zhang, Mihir Shetty, Valentino Clemente, Stig T. Linder, Martina Bazzaro · 2021 · International Journal of Molecular Sciences
  2. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC
    Sukanya Panja, Mihai Ioan Truica, Christina Y. Yu, Vamshi Saggurthi, Michael W. Craige, Katie Whitehead, Mayra Vendramini Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan et al. · 2024 · Nature Communications
  3. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer
    Hiroyuki Yasojima, Atsushi Shimomura, Yasuto Naoi, Kazuki Kishi, Yousuke Baba, Kenzo Shimazu, Takahiro Nakayama, Seung Jin Kim, Yasuhiro Tamaki, Shinzaburo Noguchi · 2011 · European Journal of Cancer
  4. p27Kip1 Mediates Addiction of Ovarian Cancer Cells to MYCC (c-MYC) and Their Dependence on MYC Paralogs
    Tulsiram Prathapam, Alexey A. Aleshin, Yinghui Guan, Joe W. Gray, G. Steven Martin · 2010 · Journal of Biological Chemistry
  5. Inhibition of MAPKs, Myc/Max, NFκB, and Hypoxia Pathways by Phyllanthus Prevents Proliferation, Metastasis and Angiogenesis in Human Melanoma (MeWo) Cancer Cell Line
    Yin-Quan Tang, Indu Bala Jaganath, Rishya Manikam, Shamala Devi Sekaran · 2014 · International Journal of Medical Sciences
  6. Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance
    Ismael Soltani, Kaïs Douzi, Hanen Gharbi, Islem Ben Hassine, Mouheb Teber, Hassiba Amouri, Hind Ben Hadj Othmen, Ahlem Farrah, Raihane Ben Lakhal, Salem Abbès et al. · 2016 · Hematology
  7. TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer
    Xiaoting Jia, Zhijie Zhang, Kai Luo, Guopei Zheng, Minying Lu, Ying Song, Hao Liu, Huisi Qiu, Zhimin He · 2017 · Scientific Reports
  8. Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
    Candace J. Poole, Wenli Zheng, Haesung Lee, Danielle Young, Atul Lodh, Ahmed Chadli, Jan van Riggelen · 2018 · Cancers
  9. Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy
    A. Vera de Jonge, Tuna Mutis, Margaretha G.M. Roemer, Blanca Scheijen, Martine E.D. Chamuleau · 2020 · Cancers
  10. Genetic unraveling of colorectal cancer
    Sabha Rasool, Vamiq Rasool, Tahira Naqvi, Bashir Ahmad Ganai, Bhahwal Ali Shah · 2014 · Tumor Biology
  11. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1in laryngeal squamous cell carcinoma
    Min Yang, Wei Li, Yi-Ying Liu, Shuang Fu, Guang-Bin Qiu, Kailai Sun, Wei‐Neng Fu · 2012 · BMC Cancer
  12. Inhibition of Mxi1 suppresses HIF-2α-dependent renal cancer tumorigenesis
    Chun Chui Tsao, Bin Tean Teh, Eric Jonasch, Nicole Schreiber‐Agus, Eleni Efstathiou, Anh G. Hoang, P. Bogdan Czerniak, Christopher J. Logothetis, Paul Gettys Corn · 2008 · Cancer Biology & Therapy
  13. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets
    Séverine Pascal, Yves Guiot, Stella Pelengaris, Michael Khan, Jean‐Christophe Jonas · 2008 · American Journal of Physiology-Endocrinology and Metabolism
  14. MYC-Targeting PROTACs Lead to Bimodal Degradation and N-Terminal Truncation
    Shelton R. Boyd, Srinivas Chamakuri, Alexander J. Trostle, Hu Chen, Zhandong Liu, Antrix Jain, Jian Wang, Anna Malovannaya, Damian W. Young · 2025 · ACS Chemical Biology
  15. Targeted degradation of CDK9 potently disrupts the MYC-regulated network
    Mohammed A. Toure, Keisuke Motoyama, Yichen Xiang, Julie Urgiles, Florian Kabinger, Ann-Sophie Koglin, Ramya S. Iyer, Kaitlyn Gagnon, Amruth Kumar, Samuel Ojeda et al. · 2025 · Cell chemical biology
  16. An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy
    Teng Xiong, Mengyao Wang, Jing Zhao, Qing Liu, Chao Yang, Wen Luo, Xiangchun Li, Huanming Yang, Karsten Kristiansen, Bhaskar Roy et al. · 2017 · Oncotarget
  17. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
    Alba Loras, Cristina Segovia, José Luis Ruiz-Cerdá · 2021 · Cancers
  18. Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex vivo treated pediatric T-cell acute lymphoblastic leukemia cells
    Daniela Kužílková, Cristina Bugarin, Kateřina Rejlová, Axel Ronald Schulz, Henrik E. Mei, Maddalena Paganin, Alessandra Biffi, Andrea Biondi, Tomáš Kalina, Giuseppe Gaipa · 2021 · Haematologica
  19. Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype
    Marianna Aprile, Simona Cataldi, Caterina Perfetto, Antonio Federico, Alfredo Ciccodicola, Valerio Costa · 2023 · British Journal of Cancer
  20. Profiling and bioinformatic analysis of circular RNA expression regulated by c-Myc
    Qiheng Gou, Ke Wu, Jiankang Zhou, Yuxin Xie, Lunxu Liu, Yong Peng · 2017 · Oncotarget
  21. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer
    Cuiling Zhou, Gang Che, Xiaobin Zheng, Junlan Qiu, Zhinan Xie, Yunyan Cong, Xiaofeng Pei, Hongyu Zhang, Huanhuan Sun, Haiqing Ma · 2019 · Journal of Cancer Research and Clinical Oncology
  22. Myc-Miz-1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ
    Lei Zhang, Jing Li, Hui Xu, Xianyu Shao, Li Fu, Ye Hou, Caiqing Hao, Wenyan Li, Kanak Joshi, Wei Wei et al. · 2020 · Blood
  23. RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin
    Cheng‐Wei Lin, Gi‐Ming Lai, Ku‐Chung Chen, Tsung-Han Lin, Jhen-Jia Fan, Rhu-Long Hsu, Chih‐Ming Chou, Chun‐Mao Lin, Chithan C. Kandaswami, Ming‐Ting Lee et al. · 2015 · Journal of Functional Foods
  24. Modulating the Functional Contributions of c-Myc to the Human Endothelial Cell Cyclic Strain Response
    Nicole E. Hurley, Lisa A. Schildmeyer, Kami A. Bosworth, Yumiko Sakurai, Suzanne G. Eskin, Laurence H. Hurley, Larry V. McIntire · 2009 · Journal of Vascular Research
  25. Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth
    NATTANAN LOSUWANNARAK, Sittiruk Roytrakul, Pithi Chanvorachote B · 2020 · Cancer Genomics & Proteomics
  26. Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia
    Huabo Wang, Jie Li Lu, Frances Alencastro, Alexander Roberts, Julia Fiedor, Patrick A. Carroll, Robert N. Eisenman, Sarangarajan Ranganathan, Michael S Torbenson, Andrew W. Duncan et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
  27. Myc inhibition tips the immune balance to promote antitumor immunity
    Chao Yang, Yun Liu, Yudi Hu, Liang Fang, Zhe Huang, Huanhuan Cui, Jun Xie, Yazhen Hong, Wei Chen, Nengming Xiao et al. · 2022 · Cellular and Molecular Immunology
  28. Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines
    Laurent Chouchana, Ana A. Fernández-Ramos, Florent Dumont, Catherine Marchetti, Irène Ceballos-Picot, Philippe H. Beaune, David Gurwitz, Marie‐Anne Loriot · 2015 · Genome Medicine
  29. AP4 is required for mitogen- and c-MYC-induced cell cycle progression
    René Jackstadt, Heiko Hermeking · 2014 · Oncotarget
  30. MiR-17-5p and miR-20a promote chicken cell proliferation at least in part by upregulation of c-Myc via MAP3K2 targeting
    Xiao-Fei Zhang, He Song, Shupei Qiao, Jing Liu, Tianyu Xing, Xiaohong Yan, Hui Li, Ning Wang · 2017 · Scientific Reports
  31. Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo
    Keqi Song, Lan Dai, Xiaoran Long, Xiaojuan Cui, Yixuan Liu, Wen J. Di · 2019 · OncoTargets and Therapy
  32. Germinal Centre B Cell Functions and Lymphomagenesis: Circuits Involving MYC and MicroRNAs
    Marcela Cristina Robaina, Luciano Mazzoccoli, Claudete Esteves Klumb · 2019 · Cells
  33. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer
    Weiyu Pan, Weixia Wang, Jie Huang, Kui Lu, Sinian Huang, Dongxian Jiang, Dacheng Bu, Jing Liu, Hongyan Jing, Junxia Yao et al. · 2019 · Japanese Journal of Clinical Oncology
  34. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy
    Yalda Baghay Esfandyari, Mohammad Amin Doustvandi, Mohammad Ali Amini, Behzad Baradaran, Sheyda Jodeiry Zaer, Nazila Mozammel, Mehdi Mohammadzadeh, Ahad Mokhtarzadeh · 2021 · Reproductive Sciences
  35. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer
    Xuan Yang, Dacheng Fan, Aidan Henry Troha, Hyunjun Max Ahn, Kun Qian, Bo Liang, Yuhong Du, Haian Fu, Andrei A. Ivanov · 2021 · Bioorganic & Medicinal Chemistry
  36. Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration
    Rafael Lani‐Louzada, Camila Marra, Mariana Santana Dias, Victor G. Araújo, Carla Andreia Abreu, Vinícius Toledo Ribas, Daniel Adesse, Silvana Allodi, Vince A. Chiodo, William W. Hauswirth et al. · 2022 · Investigative Ophthalmology & Visual Science
  37. Inhibition of the Single Downstream Target BAG1 Activates the Latent Apoptotic Potential of MYC
    Xiao‐Yong Zhang, Harla K. Pfeiffer, Hestia S. Mellert, Timothy J. Stanek, Robyn T. Sussman, Alpana Kumari, Duonan Yu, Isidore Rigoutsos, Andrei Thomas‐Tikhonenko, Hans E. Seidel et al. · 2011 · Molecular and Cellular Biology
  38. c-Myc activation promotes cofilin-mediated F-actin cytoskeleton remodeling and telomere homeostasis as a response to oxidant-based DNA damage in medulloblastoma cells
    Anna Lewińska, Jolanta Klukowska‐Rötzler, Anna Deręgowska, Jagoda Adamczyk‐Grochala, Maciej Wnuk · 2019 · Redox Biology
  39. Epigenetic reprogramming of Myc target genes.
    Stefano Amente, Luigi Lania, Barbara Majello · 2011 · Europe PMC (PubMed Central)
  40. Protein phosphatase 1 regulatory subunit 15 A promotes translation initiation and induces G2M phase arrest during cuproptosis in cancers
    Chunyu Liu, Liang Chen, Yukun Cong, Lulin Cheng, Yujun Shuai, Fang Lv, Kang Chen, Yarong Song, Y. Xing · 2024 · Cell Death and Disease
  41. Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level
    Xianjing Hu, Sarwat Fatima, Minting Chen, Tao Huang, Yuen Wa Chen, Rui‐Hong Gong, Hoi Leong Xavier Wong, Rongmin Yu, Liyan Song, Hiu Yee Kwan et al. · 2021 · Cell Death and Disease
  42. Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer
    Matthias Läsche, Julia K. S. Gallwas, Carsten Gründker · 2022 · International Journal of Molecular Sciences
  43. EST12 regulates Myc expression and enhances anti-mycobacterial inflammatory response via RACK1-JNK-AP1-Myc immune pathway
    Jian Wu, Fengling Luo, Yan Xie, Huan Xiong, Yadong Gao, Guanghui Liu, Xiao‐Lian Zhang · 2022 · Frontiers in Immunology
  44. Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network
    Edward V. Prochownik · 2022 · Cells
  45. Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia
    Kimberly B. Johansson, Megan S. Zimmerman, I. V. Dmytrenko, Feng Gao, Daniel C. Link · 2023 · Leukemia
  46. Sodium Butyrate Efficiently Converts Fully Reprogrammed Induced Pluripotent Stem Cells from Mouse Partially Reprogrammed Cells
    Seok Jin Kang, Young-Il Park, ByungJae So, Hwan‐Goo Kang · 2014 · Cellular Reprogramming
  47. Identification of differentially expressed genes in the digestive gland of manila clam Ruditapes philippinarum exposed to BDE-47
    Jingjing Miao, Luqing Pan, Wenhao Zhang, Dong Liu, Yuefeng Cai, Zhen Li · 2014 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
  48. Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer
    Yujiro Nishizawa, Naohiro Nishida, Masamitsu Konno, Koichi Kawamoto, Ayumu Asai, Jun Koseki, Hidekazu Takahashi, Naotsugu Haraguchi, Junichi Nishimura, Taishi Hata et al. · 2016 · Annals of Surgical Oncology
  49. High Frequency of Bone Marrow Involvement in Intravascular Large B-Cell Lymphoma
    Jianchao Wang, Wenshuang Ding, Limin Gao, Wenqing Yao, Min Chen, Sha Zhao, Weiping Liu, Wenyan Zhang · 2016 · International Journal of Surgical Pathology
  50. T cell metabolism in metabolic disease-associated autoimmunity
    Jacob Amersfoort, Johan Kuiper · 2017 · Immunobiology
  51. The role of exosomal shuttle RNA (esRNA) in lymphoma
    Jiwei Li, Tian Tian, Xiaoyan Zhou · 2019 · Critical Reviews in Oncology/Hematology
  52. Exploring MYC relevance to cancer biology from the perspective of cell competition
    Simona Paglia, Manuela Sollazzo, Simone Di Giacomo, Silvia Strocchi, Daniela Grifoni · 2019 · Seminars in Cancer Biology
  53. Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models
    Eleonora Vecchio, Giuseppe Fiume, Serena Correnti, Salvatore Romano, Enrico Iaccino, Selena Mimmi, Domenico Maisano, Nancy Nisticò, Ileana Quinto · 2020 · International Journal of Molecular Sciences
  54. c-Myc protein is degraded in response to UV irradiation
    Sébastien Britton, Bernard Salles, Patrick Calsou · 2008 · Cell Cycle
  55. An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II
    Victoria H. Cowling, Michael D. Cole · 2007 · Oncogene
  56. Measuring Oncogenic Signaling Pathways in Cancer with PET: An Emerging Paradigm from Studies in Castration-Resistant Prostate Cancer
    Michael J. Evans · 2012 · Cancer Discovery
  57. Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential
    Zhong Zhang, Haijun Zhang · 2021 · Expert Opinion on Therapeutic Targets
  58. Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription
    Melanie M. Frigault, Arushi Mithal, Harvey Wong, Beatrix Stelte‐Ludwig, Vinay Mandava, Xin Huang, Joseph Birkett, Amy Jo Johnson, Raquel E. Izumi, Ahmed Hamdy · 2023 · Cancer Research Communications
  59. Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity
    Chen Li, Chengxi Sun, Kunal Das Mahapatra, Pilvi Riihilä, Jaakko S. Knuutila, Liisa M. Nissinen, Jan Lapins, Veli‐Matti Kähäri, Bernhard Homey, Enikö Sonkoly et al. · 2023 · British Journal of Dermatology
  60. Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation
    Douglas J. Hartman, David G. Binion, Miguel D. Regueiro, Caitlyn Miller, Cameron Herbst, Reetesh K. Pai · 2018 · Inflammatory Bowel Diseases
  61. Diabetic GK/Par rat β-cells are spontaneously protected against H2O2-triggered apoptosis. A cAMP-dependent adaptive response
    Grégory Lacraz, Florence Figeac, Jamileh Movassat, Nadim Kassis, Bernard Portha · 2009 · American Journal of Physiology-Endocrinology and Metabolism
  62. Molecular Pathogenesis of Prostate Cancer
    William B. Coleman · 2017 · Elsevier eBooks
  63. The Role of Wnt/β-Catenin Signaling in Enterocyte Turnover during Methotrexate-Induced Intestinal Mucositis in a Rat
    Igor Sukhotnik, Tatiana Geyer, Yulia Pollak, Jorge G. Mogilner, Arnold G. Coran, Drora Berkowitz · 2014 · PLoS ONE
  64. Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression
    Rudolf Götz · 2008 · Cancer Cell International
  65. A multi-omics genome-and-transcriptome single-cell atlas of human preimplantation embryogenesis reveals the cellular and molecular impact of chromosome instability
    Elia Fernandez Gallardo, Alejandro Sifrim, Joel Chappell, Jonas Demeulemeester, Jennifer Clara Herrmann, Robin Vermotte, Alison Kerremans, Michiel Van der Haegen, Jens Van Herck, Sebastiaan Vanuytven et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  66. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification
    Elizabeth A. Price, Roopal Patel, Irene B. Scheimberg, Esin Kotiloğlu Karaa, Mandeep S. Sagoo, Maddy Ashwin Reddy, Zerrin Onadim · 2021 · Ophthalmic Genetics
  67. MYC overexpression is associated with an early disease progression from MDS to AML
    David C. Gajzer, Constantine Logothetis, David Andrew Sallman, Gregoire Calon, Abida Poovathukaran Babu, Onyee Chan, Nicole D. Vincelette, Virginia Olivia Volpe, Najla H. Al Ali, Pukhraz Basra et al. · 2021 · Leukemia Research
  68. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells
    Roghayeh Ghorbani, Mahmoud Gharbavi, Ali Sharafi, Elham Rismani, Hamed Rezaeejam, Yousef Mortazavi, Behrooz Johari · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  69. Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
    Thomas F. Cyberski, Alka Singh, Michael Korzinkin, Vasudha Mishra, Frank W. Pun, Le Shen, Claudia Wing, Xiangying Cheng, Brandon J. Baird, Yuxuan Miao et al. · 2024 · npj Precision Oncology
  70. Genome-Wide Dissection of Posttranscriptional and Posttranslational Interactions
    Mukesh Bansal, Andrea Califano · 2011 · Methods in molecular biology
  71. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas
    Maohua Ding, Zhen Wang, Lei Jiang, Hualin Fu, Jie Gao, Xianbin Lin, Chunlei Zhang, Zhenyang Liu, Yifei Shi, Guanzhong Qiu et al. · 2015 · Biomaterials
  72. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures
    Harvey E. Johnston, Matthew J. Carter, Kerry L. Cox, Melanie Dunscombe, Antigoni Manousopoulou, Paul A. Townsend, Spiros D. Garbis, Mark Steven Cragg · 2017 · Molecular & Cellular Proteomics
  73. MYC is downregulated by a mitochondrial checkpoint mechanism
    Xiaonan Zhang, Arjan Mofers, Per Hydbring, Maria Hägg Olofsson, Jing Guo, Stig T. Linder, Pádraig D’Arcy · 2017 · Oncotarget
  74. Targeting G-Quadruplex DNA for Cancer Chemotherapy
    Pratap Chandra Acharya, Sumanta Debbarma · 2022 · Current Drug Discovery Technologies
  75. p63α modulates c-Myc activity via direct interaction and regulation of MM1 protein stability
    Anning Han, Juan Li, Yimin Li, Yang Wang, Johann S. Bergholz, Yujun Zhang, Chenghua Li, Zhi‐Xiong Jim Xiao · 2016 · Oncotarget
  76. Complex Gene Regulatory Networks – from Structure to Biological Observables: Cell Fate Determination
    Sui Huang, Stuart Alan Kauffman · 2011 · Springer eBooks
  77. mrtl—A translation/localization regulatory protein encoded within the human c‐myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network
    Hyoungsoo Choi, Nateka L. Jackson, Denise R. Shaw, Peter Dean Emanuel, Y. Lucy Liu, Albert Tousson, Zheng Meng, Scott W. Blume · 2008 · Journal of Cellular Biochemistry
  78. Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CX3CR1+ synovial lining macrophage barrier
    Lei Wang, Ming Hao, Yongyue Xu, Zhaoyan Wang, Hanqi Xie, Bo Zhang, Xue Zhang, Jun Lin, Xiaodan Sun, Jianbin Wang et al. · 2025 · Stem Cell Research & Therapy
  79. The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis
    Zhao Min, Zhang Xunlei, Chen Haizhen, Zhao Wenjing, Haiyan Yu, Xiaoyun Lu, Zhou Jian-yun, Chen Xudong, Shen Aiguo · 2021 · Frontiers in Bioinformatics
  80. MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging
    Brian C. Grieb, Christine M. Eischen · 2022 · Biology
  81. Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model
    Thuy Xuan Phan, Vu H. Nguyen, Rui Jun Su, Yangchan Li, Ying Qing, Hanjun Qin, Hyejin Cho, Lei Jiang, Xiwei Wu, Jianjun Chen et al. · 2023 · Frontiers in Oncology
  82. Targeting SMYD2 inhibits prostate cancer cell growth by regulating c‐Myc signaling
    Junhong Li, Fangning Wan, Junyu Zhang, Shengfeng Zheng, Yunjie Yang, Zhe Hong, Bo Dai · 2023 · Molecular Carcinogenesis
  83. The genomic stability of induced pluripotent stem cells
    Zhao Chen, Tongbiao Zhao, Yang Xu · 2012 · Protein & Cell
  84. Molecular diagnostics complementing morphology in superficial mesenchymal tumors
    Alison L. Cheah, John R. Goldblum, Steven D. Billings · 2013 · Seminars in Diagnostic Pathology
  85. CD47 limits autophagy to promote acute kidney injury
    Maryam El‐Rashid, Kedar Ghimire, Barkha Singhal Sanganeria, Bo Lü, and Natasha M. Rogers · 2019 · The FASEB Journal
  86. The Intestinal Tumour Microenvironment
    Julia K. H. Leman, Luis Munoz‐Erazo, Roslyn A. Kemp · 2020 · Advances in experimental medicine and biology
  87. Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy
    Wentao Chen, Kurt Yun Mou, Paige E. Solomon, Rahul Raj Aggarwal, Kevin Leung, James A. Wells · 2021 · Proceedings of the National Academy of Sciences
  88. Selective Targeting of the Repressive Transcription Factors YY1 and cMyc to Disrupt Quiescent Human Immunodeficiency Viruses
    Kirston Barton, David M. Margolis · 2012 · AIDS Research and Human Retroviruses
  89. The NRF2 Activation and Antioxidative Response Are Not Impaired Overall during Hyperoxia-Induced Lung Epithelial Cell Death
    Haranatha R. Potteti, Narsa M. Reddy, Tom K. Hei, Dhananjaya V. Kalvakolanu, Sekhar P. Reddy · 2013 · Oxidative Medicine and Cellular Longevity
  90. The Endoplasmic Reticulum Chaperone GRP78 Also Functions as a Cell Surface Signaling Receptor
    Udhayakumar Gopal, Salvatore Vincent Pizzo · 2018 · Elsevier eBooks
  91. The conserved Myc box 2 and Myc box 3 regions are important, but not essential, for Myc function in vivo
    Daniela Schwinkendorf, Peter Gallant · 2009 · Gene
  92. c-Myc promotes metabolic reprogramming in pulmonary hypertension via the stimulation of glutaminolysis and the reductive tricarboxylic acid cycle
    Manivannan Yegambaram, Xutong Sun, Qing Lü, Alejandro Garcia Flores, Marina Zemskova, Jamie E. Soto, Adam J. Rauckhorst, Emin Maltepe, Ting Wang, Jeffrey R. Fineman et al. · 2025 · Redox Biology
  93. The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
    Lotteke J. Y. M. Ziel-Swier, Yichen Liu, Annika Seitz, Debora de Jong, Jasper A. Koerts, Bea Rutgers, Rianne N. Veenstra, Fazlyn Reeny Abdul Razak, Agnieszka Dzikiewicz‐Krawczyk, Anke van den Berg et al. · 2022 · Genes
  94. The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis
    Weibin Wu, Ai Chen, Siming Lin, Qiuran Wang, Guili Lian, Li Luo, Liangdi Xie · 2022 · BMC Pulmonary Medicine
  95. PI3K/ c-Myc/AFF4 axis promotes pancreatic tumorigenesis through fueling nucleotide metabolism
    Chenming Ni, Wen‐Yu Liu, Kailian Zheng, Shiwei Guo, Bin Song, Wei Jing, Gang Li, Bo Li, Can-rong Ni, Keqing Shi et al. · 2023 · International Journal of Biological Sciences
  96. Small-Molecule Approaches to Target Transcription Factors
    Huarui Cui, Morgan Stilgenbauer, Angela N. Koehler · 2024 · Annual Review of Cancer Biology
  97. Exercise-Induced MYC as an Epigenetic Reprogramming Factor That Combats Skeletal Muscle Aging
    Ronald G. Jones, Ferdinand von Walden, Kevin A. Murach · 2024 · Exercise and Sport Sciences Reviews
  98. Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer
    Wen-Xiao Yang, Luo Hong, Lin-Wei Guo, Yun-Jin Wang, Xiang-Chen Han, Bo-Yue Han, Zheng Xing, Guo-Liang Zhang, Hongxia Zhou, Chao Chen et al. · 2024 · Cell Discovery
  99. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47 000 MW acid labile protein in CD4+ T‐cell recognition
    Jason M. God, Dan Zhao, Christine A. Cameron, Shereen Amria, Jennifer Rutherford Bethard, Azizul Haque · 2014 · Immunology
  100. Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma
    Yi Gong, Xi Zhang, Rui Chen, Wei Yan, Zhongmin Zou, Xinghua Chen · 2017 · PeerJ